RecruitingNCT05530304

Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.


Sponsor

University Hospital Muenster

Enrollment

30 participants

Start Date

Feb 9, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.


Eligibility

Plain Language Summary

Simplified for easier understanding

This registry study is tracking the outcomes of patients who receive a specific type of stent graft device (a triple inner branched aortic arch stent graft from Terumo Aortic) used to treat diseases of the aortic arch — the curved section of the main blood vessel leaving the heart. The study is collecting data from multiple centers to build evidence on how well this device works and how safe it is over time. You may be eligible if... - You are 18 years old or older - You have a condition affecting the aortic arch - Your treatment plan includes a triple inner branch stent graft from Terumo Aortic - You are able to attend follow-up appointments You may NOT be eligible if... - You are a woman of childbearing age - You are under 18 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETriple inner branched arch stentgraft

New findings regarding treatment planning and management of patients with aortic arch pathologies.


Locations(1)

Muenster University Hospital

Münster, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05530304


Related Trials